Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,320
datasets available to search
ShareScore release 0.9.0
Dataset results
1,320 results for “Cystic fibrosis”
Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy
ClinicalTrials.gov study NCT04378153. IPD Sharing: NO. Countries: 1. Publications: 4.
Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa
ClinicalTrials.gov study NCT00757237. IPD Sharing: Not stated. Countries: 13. Publications: 1.
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
ClinicalTrials.gov study NCT01705145. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation
ClinicalTrials.gov study NCT02564354. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
ClinicalTrials.gov study NCT00909532. IPD Sharing: Not stated. Countries: 8. Publications: 4.
A Study of Ataluren in Pediatric Participants With Cystic Fibrosis
ClinicalTrials.gov study NCT00458341. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Study Evaluating the Efficacy and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for F508del
ClinicalTrials.gov study NCT04105972. IPD Sharing: NO. Countries: 4. Publications: 3.
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis
ClinicalTrials.gov study NCT00757848. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
ClinicalTrials.gov study NCT01755455. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation
ClinicalTrials.gov study NCT02516410. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
ClinicalTrials.gov study NCT00528190. IPD Sharing: NO. Countries: 1. Publications: 1.
Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis
ClinicalTrials.gov study NCT01355796. IPD Sharing: Not stated. Countries: 1. Publications: 15.
A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis
ClinicalTrials.gov study NCT03559062. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years
ClinicalTrials.gov study NCT04537793. IPD Sharing: NO. Countries: 5. Publications: 3.
Rollover Study of VX-770 in Cystic Fibrosis Subjects
ClinicalTrials.gov study NCT01117012. IPD Sharing: Not stated. Countries: 8. Publications: 1.
Pharmacokinetics of Omadacycline in Cystic Fibrosis
ClinicalTrials.gov study NCT04460586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients
ClinicalTrials.gov study NCT00677365. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
ClinicalTrials.gov study NCT02797132. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
ClinicalTrials.gov study NCT00104520. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cystic Fibrosis Related Bone Disease: the Role of CFTR
ClinicalTrials.gov study NCT01549314. IPD Sharing: Not stated. Countries: 1. Publications: 6.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.